The coronavirus (COVID-19) pandemic has spread swiftly from the Chinese city Wuhan across the world. In Hong Kong, the number of active cases amounted to 260,919 with 9,389 deaths as of June 7, 2022. The financial hub was one of the places which were able to flatten the pandemic curve for a long time before the Omicron variant. To boost the low inoculation rate, Hong Kong government has widened the COVID-19 vaccine access to all residents aged 16 and older.

This layer shows the location of all visited and resided buildings of probable or confirmed COVID-19 cases in Hong Kong. It is a set of data made available by the Department of Health under the Government of Hong Kong Special Administrative Region (the "Government") at https://GEODATA.GOV.HK/ ("Hong Kong Geodata Store"). The source data is in GML format and has been processed and converted into Esri File Geodatabase format and uploaded to Esri's ArcGIS Online platform for sharing and reference purpose. The objectives are to facilitate our Hong Kong ArcGIS Online users to use the data in a spatial ready format and save their data conversion effort.For details about the data, source format and terms of conditions of usage, please refer to the website of Hong Kong Geodata Store at https://geodata.gov.hk/.

Hong Kong recorded 1283514 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, Hong Kong reported 9427 Coronavirus Deaths. This dataset includes a chart with historical data for Hong Kong Coronavirus Cases.

As of December 12, 2022, Hong Kong had the highest rate of coronavirus (COVID-19) cases reported in the previous seven days in the Asia-Pacific region, around 1.19 thousand cases per 100 thousand people. South Korea followed with 825 cases per 100,000 people in the past seven days.

JHU Has Stopped Collecting Data As Of 03/10/2023

After three years of around-the-clock tracking of COVID-19 data from around the world, Johns Hopkins has discontinued the Coronavirus Resource Center’s operations.

The site’s two raw data repositories will remain accessible for information collected from 1/22/20 to 3/10/23 on cases, deaths, vaccines, testing and demographics.

Novel Corona Virus (COVID-19) epidemiological data since 22 January 2020. The data is compiled by the Johns Hopkins University Center for Systems Science and Engineering (JHU CCSE) from various sources including the World Health Organization (WHO), DXY.cn, BNO News, National Health Commission of the People’s Republic of China (NHC), China CDC (CCDC), Hong Kong Department of Health, Macau Government, Taiwan CDC, US CDC, Government of Canada, Australia Government Department of Health, European Centre for Disease Prevention and Control (ECDC), Ministry of Health Singapore (MOH), and others. JHU CCSE maintains the data on the 2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository on Github.

Fields available in the data include Province/State, Country/Region, Last Update, Confirmed, Suspected, Recovered, Deaths.

On 23/03/2020, a new data structure was released. The current resources for the latest time series data are:

• time_series_covid19_confirmed_global.csv
• time_series_covid19_deaths_global.csv
• time_series_covid19_recovered_global.csv

---DEPRECATION WARNING---
The resources below ceased being updated on 22/03/2020 and were removed on 26/03/2020:

• time_series_19-covid-Confirmed.csv
• time_series_19-covid-Deaths.csv
• time_series_19-covid-Recovered.csv

In Hong Kong, COVID-19 had the largest number of cases among all the infectious diseases in 2021, with more than 3,800 notified cases. The second-highest number of infectious diseases recorded in Hong Kong was tuberculosis, followed by chickenpox.

The outbreak of the novel coronavirus in Wuhan, China, saw infection cases spread throughout the Asia-Pacific region. By April 13, 2024, India had faced over 45 million coronavirus cases. South Korea followed behind India as having had the second highest number of coronavirus cases in the Asia-Pacific region, with about 34.6 million cases. At the same time, Japan had almost 34 million cases. At the beginning of the outbreak, people in South Korea had been optimistic and predicted that the number of cases would start to stabilize. What is SARS CoV 2?Novel coronavirus, officially known as SARS CoV 2, is a disease which causes respiratory problems which can lead to difficulty breathing and pneumonia. The illness is similar to that of SARS which spread throughout China in 2003. After the outbreak of the coronavirus, various businesses and shops closed to prevent further spread of the disease. Impacts from flight cancellations and travel plans were felt across the Asia-Pacific region. Many people expressed feelings of anxiety as to how the virus would progress. Impact throughout Asia-PacificThe Coronavirus and its variants have affected the Asia-Pacific region in various ways. Out of all Asia-Pacific countries, India was highly affected by the pandemic and experienced more than 50 thousand deaths. However, the country also saw the highest number of recoveries within the APAC region, followed by South Korea and Japan.

In past 24 hours, Hong Kong, Asia had 696 new cases, 34 deaths and N/A recoveries.

Pattern of TCIM use before and during COVID-19 (n = 632).

This is the data for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). Also, Supported by ESRI Living Atlas Team and the Johns Hopkins University Applied Physics Lab (JHU APL).Data SourcesWorld Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus

As of June 6, 2022, the novel coronavirus SARS-CoV-2 that originated in Wuhan, the capital of Hubei province in China, had infected over 2.1 million people and killed 14,612 in the country. Hong Kong is currently the region with the highest active cases in China.

From Wuhan to the rest of China

In late December 2019, health authorities in Wuhan detected several pneumonia cases of unknown cause. Most of these patients had links to the Huanan Seafood Market. With Chinese New Year approaching, millions of Chinese migrant workers travelled back to their hometowns for the celebration. Before the start of the travel ban on January 23, around five million people had left Wuhan. By the end of January, the number of infections had surged to over ten thousand. The death toll from the virus exceeded that of the SARS outbreak a few days later. On February 12, thousands more cases were confirmed in Wuhan after an improvement to the diagnosis method, resulting in another sudden surge of confirmed cases. On March 31, 2020, the National Health Commission (NHC) in China announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. On April 17, 2020, health authorities in Wuhan revised its death toll, adding 50 percent more fatalities. After quarantine measures were implemented, the country reported no new local coronavirus COVID-19 transmissions for the first time on March 18, 2020.

The overloaded healthcare system

In Wuhan, 28 hospitals were designated to treat coronavirus patients, but the outbreak continued to test China’s disease control system and most of the hospitals were soon fully occupied. To combat the virus, the government announced plans to build a new hospital swiftly. On February 3, 2020, Huoshenshan Hospital was opened to provide an additional 1,300 beds. Due to an extreme shortage of health-care professionals in Wuhan, thousands of medical staff from all over China came voluntarily to the epicenter to offer their support. After no new deaths reported for first time, China lifted ten-week lockdown on Wuhan on April 8, 2020. Daily life was returning slowly back to normal in the country.

Mexico SALUD: COVID-19: Confirmed Cases: New data was reported at 0.000 Person in 24 Oct 2022. This stayed constant from the previous number of 0.000 Person for 23 Oct 2022. Mexico SALUD: COVID-19: Confirmed Cases: New data is updated daily, averaging 4,793.500 Person from Feb 2020 (Median) to 24 Oct 2022, with 970 observations. The data reached an all-time high of 60,552.000 Person in 19 Jan 2022 and a record low of 0.000 Person in 24 Oct 2022. Mexico SALUD: COVID-19: Confirmed Cases: New data remains active status in CEIC and is reported by Ministry of Health. The data is categorized under High Frequency Database’s Disease Outbreaks – Table MX.D001: Ministry of Health: Coronavirus Disease 2019 (COVID-2019) (Discontinued). Current day data is released daily between 7PM and 11PM Mexico City Time. Weekend data are updated following Monday morning, Hong Kong Time. As of Oct 07, cases confirmed by clinical-epidemiological association to COVID-19 are included on the count of Confirmed Cases and Deaths. These cases are suspected cases or those who has symptoms but were unable to have a test or received medical attention before dying.

As of February 11, 2020, the fatality rate of novel coronavirus COVID-19 (formally known as 2019-nCoV) ranged around 2.3 percent in China. The figure was higher in Hubei province, which where Wuhan city located in, reaching approximately 2.9 percent. In April, the case fatality rate of COVID-19 increased to above four percent in the country.

What is COVID-19?

Coronaviruses (CoV) are a family of a hundred viruses which can lead to potentially deadly diseases in mammals and birds. Some of them can mutate and spread from animals to humans. Common transmission routes are airborne droplets and direct contact in humans, causing fever, respiratory infections and sometimes gastrointestinal problems. The new strain of coronavirus disease in 2019 (COVID-19) is one of the seven known coronaviruses, which can infect humans with an estimated incubation period between two and 14 days. Most of the early COVID-19 cases occurred among people with a median age of 55 years old, who had been to the Huanan seafood market in Wuhan.

Comparison with SARS and MERS

COVID-19 has become one of the largest epidemics in the world. SARS and MERS are other deadly coronaviruses. In 2002 and 2003, the outbreak of severe acute respiratory syndrome (SARS) killed almost 800 people after its emergence in southern China. This was mostly in mainland China and Hong Kong. Another major virus crisis was the Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012. The virus spread to 27 countries, resulting in nearly 860 deaths. In terms of mortality rates, MERS was much higher than SARS.

Gegevens voor het "2019 Novel Coronavirus Visual Dashboard" beheerd door "the Johns Hopkins University Center for Systems Science and Engineering" (JHU CSSE). Ook ondersteund door het "ESRI Living Atlas Team" en het "Johns Hopkins University Applied Physics Lab" (JHU APL).Gegevensbronnen:World Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus

Background: The COVID-19 pandemic has led to an increasing mental health burden. We examined the factors associated with mental health symptoms in Chinese general adults in Hong Kong.Methods: We conducted a dual-frame (landline and mobile) survey on Chinese adults aged 18 years or older in April 2020. Shortage of preventive materials, perceptions of the outbreak (each item range 1–5), and reduction in income were assessed. Mental health symptoms measured included stress (Perceived Stress Scale-4, range 0–16), anxiety (General Anxiety Disorders-2, range 0–6, cutoff >2), and depressive symptoms (Patient Health Questionnaire-2, range 0–6, cutoff >2). Results were weighted by the general population distribution. Associations were analyzed by multivariable linear (for stress) and logistic (for anxiety and depressive symptoms) regression adjusting for sociodemographic and health-related covariates, including confirmed or in close contacts of confirmed cases, chronic disease, self-rated health, and smoking and alcohol drinking behavior.Results: Of the 1,501 participants (52.5% female, 55.0 aged 30–59 years), the average stress score was 7.20 (SD 2.12). 218 (15.8%) and 206 (14.8%) participants had anxiety and depressive symptoms, respectively. Shortage in facemasks (20.8%), alcohol-based hand sanitizers (13.9%), and cleaning products (7.3%) was reported. Participants generally disagree with the perception of at risk of getting infected in the coming 6 months (mean 2.2, SD 1.1), but tended to agree with the perception of worry that the people around pose a threat to them (mean 3.6, SD 0.9) and the outbreak has greatly affected their daily life (mean 3.7, SD 0.9). 59.3% employed participants had income reduction and 6.2% had become unemployed since the outbreak. Stress, anxiety, and depressive symptoms were more prevalent in those with shortages of preventive materials and negative perceptions of the outbreak (all P < 0.05). Reduction in income and unemployment were associated with more mental health symptoms (all P < 0.05).Conclusions: Shortage of preventive materials, negative perceptions, financial loss, and unemployment were prevalent during the outbreak and found in association with higher stress and more anxiety and depressive symptoms. Further research and urgent actions are warranted to relieve stress and promote mental health, targeting the many risk factors identified by our study.

Peru MINSA: COVID-19: Confirmed Cases: To Date: San Martín data was reported at 68,866.000 Person in 04 Mar 2024. This stayed constant from the previous number of 68,866.000 Person for 03 Mar 2024. Peru MINSA: COVID-19: Confirmed Cases: To Date: San Martín data is updated daily, averaging 61,672.000 Person from Mar 2020 (Median) to 04 Mar 2024, with 1449 observations. The data reached an all-time high of 68,866.000 Person in 04 Mar 2024 and a record low of 1.000 Person in 26 Mar 2020. Peru MINSA: COVID-19: Confirmed Cases: To Date: San Martín data remains active status in CEIC and is reported by Ministry of Health. The data is categorized under High Frequency Database’s Disease Outbreaks – Table PE.D001: Ministry of Health: Coronavirus Disease 2019 (COVID-2019). Previous day data is released daily between 2PM and 4PM Peru Time. Friday and Saturday data are updated following Monday morning, Hong Kong Time.

MDS: COVID-19: Confirmed Cases: To Date: North: Rondônia data was reported at 505,111.000 Person in 15 Feb 2025. This stayed constant from the previous number of 505,111.000 Person for 14 Feb 2025. MDS: COVID-19: Confirmed Cases: To Date: North: Rondônia data is updated daily, averaging 453,228.000 Person from Feb 2020 (Median) to 15 Feb 2025, with 1818 observations. The data reached an all-time high of 505,111.000 Person in 15 Feb 2025 and a record low of 0.000 Person in 19 Mar 2020. MDS: COVID-19: Confirmed Cases: To Date: North: Rondônia data remains active status in CEIC and is reported by Ministry of Health. The data is categorized under High Frequency Database’s Disease Outbreaks – Table BR.HLA001: Disease Outbreaks: COVID-19: Confirmed Cases. Current day data is released daily between 6PM and 7PM Brazil Time. Weekend data are updated following Monday morning, Hong Kong Time.

Données du "2019 Novel Coronavirus Visual Dashboard, géré par Johns Hopkins University Center for Systems Science and Engineering" (JHU CSSE). Il est également soutenu par l'équipe "ESRI Living Atlas" et "Johns Hopkins University Applied Physics Lab" (JHU APL).Sources de données:World Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus

On March 23, 2020, there were 48 imported cases of COVID-19 compared to six cases of local transmission. Imported cases are those in which the patient contracted the novel coronavirus while overseas. Singapore, along with Taiwan, Hong Kong, and China, is experiencing a so-called second wave of COVID-19 infections, brought into the country by Singapore citizens and residents returning from overseas.

Psychological health among healthcare workers (HCWs) has become a major concern since the COVID-19 outbreak. HCWs perceived risks of contracting COVID-19, in relation to depression were investigated. It was hypothesized that perceived high risk of contracting COVID-19 (close contact with cases, inadequate provision of personal protective equipment, insufficient infection control training, and presence of symptoms) would be significant predictors of depression. Our cross-sectional survey was completed by HCWs across three regions (Hubei, Guangdong, Hong Kong) between March 9 to April 9 2020 using convenience sampling. Depression was assessed using the 9-item Patient Health Questionnaire (PHQ-9). Prevalence of depression was 50.4% (95% CI: 44.5-56.2), 15.1% (10.1-21.9) and 12.9% (10.3-16.2) for HCWs in Hong Kong, Hubei and Guangdong, respectively. The strongest significant risk factors for depression, after adjustment, were HCWs who reported the greatest extent of feeling susceptible to contracting COVID-19 and those who reported the greatest difficulty obtaining face masks. HCWs whose family/peers greatly encouraged face mask use had lower prevalence of depression. Access to adequate supplies of personal protective equipment is essential for the psychological health of HCWs working in stressful environments, through potentially easing their perceptions of vulnerability to COVID-19.